Phil Jones-----Welsh School of Architecture, Cardiff University, UK Highlights  Different concepts and approaches to China's new green urban development are reviewed and analysed.  Compare and analyse these new concepts and present examples to help better understanding of the green urban development in China.  Identify the barriers to green urban development in China and propose suitable approaches to such development 2 Abstract China's rapid urbanisation has already led to the development of more large-scale cities than ever before. One result is that China is now the largest carbon emitter in the world. Meanwhile, China is facing enormous challenges in respect to environmental degradation, and limiting the use of natural resources in urban areas when it comes to balancing rapid economic development and environmental protection. To address this issue, China has to explore a new approach to urban development, namely green urban development. Various green urban theories are in the process of being formulated in China due to the difference in the responsibility of the central government and the gradual changes in national policies. The lack of a clear vision and target is a common barrier to green urban development in China. This paper reviews three new concepts and approaches to green urban development in China, and analyses how these concepts and approaches have been adopted, defined and developed within the Chinese context. Three typical projects are then selected to illustrate green city development in order to develop a better understanding of the application of the green theories of urban development in China. Finally, methods of future green urban development in China are proposed.

Background: At present, the prevalence of type 2 diabetes mellitus (T2DM) has become a major public health issue throughout the world, especially in developing countries. Notably, traditional Chinese patent medicines (TCPMs) are of great significance in the treatment of T2DM combined with conventional Western medicine therapy. However, there is a lack of comparison among all the current common TCPMs for treating T2DM. Therefore, this study intends to explore the efficacy and safety of different TCPMs against T2DM through the Bayesian network meta-analysis (NMA). Methods: We will conduct a comprehensive and systematic search for randomized controlled trials (RCTs) of TCPM for the treatment of T2DM in both Chinese and English databases published till August 2020. Two researchers will be responsible for screening eligible literature, extracting data, and assessing the risk of bias of included studies independently. Then, pairwise meta-analyses and Bayesian network meta-analyses will be conducted to assess all available evidence. In the end, data will be analyzed using STATA15.0 and WinBUGS1.4.3 software. Conclusion: This study will compare the efficacy and safety of different TCPMs against T2DM in detail. Our findings will provide a reliable evidence for selecting clinical treatment program and guideline development of T2DM.

Background: Scapulohumeral periarthritis is a disease with high incidence and great pain. The current western treatments with many side effects, poor efficacy cannot fundamentally solve the problem. Complementary and alternative therapies have played an excellent role in the treatment of scapulohumeral periarthritis. However, it is not clear which complementary and alternative therapy is more effective. Therefore, we propose a protocol to compare the efficacy and safety of various complementary and alternative therapies through network meta-analysis (NMA) to provide choice guidance for the therapy. Methods: A comprehensive search will be conducted for randomized controlled trials of complementary and alternative therapy for scapulohumeral periarthritis as well as ongoing trials. The time limit is from the establishment of the database until January 2021. Literature and data extraction were completed independently by two researchers. Through pairwise comparison and meta-analysis of Bayesian NMA, all the evidences are evaluated comprehensively. STATA16.0 and WinBUGS1.4.3 software will be used for data processing and analysis, and recommendation evaluation will be used to develop and assess grades to classify the quality of NMA evidence. Results: Through the analysis, we will obtain the ranking of the efficacy and safety of different complementary and alternative therapies in the treatment of scapulohumeral periarthritis, in order to provide reference for clinical selection of treatment methods. Conclusion: Complementary and alternative therapies of scapulohumeral periarthritis plays a positive role in improving the symptoms of scapulohumeral periarthritis. This study can provide evidence support for clinicians and patients. International Platform of Registered Systematic Review and Meta-Analysis Protocols registration number: INPLASY202140044.

No abstract